I’m feeling kinda lazy but part of me wants to include links to six other large studies that show severe critical mortality in the 28%-42% range of coarse not many of them state how many were severe how many critical much like cd-12 trial it’s a mix. However because investigational drug ans doctors for Bette part of last 6 months excluding last month half when more journals were published were likely giving it to critical patients more than severe which would put majority of deaths in the placebo arm where they did not get the life saving leronlimab. I’m feeling really good about the upcoming unblinding as results. Side note I see shirts stating if we don’t see results in x amount of days they are bad. That is a elementary school type statement although I wish FDA would Make out trial priority number one put a rush on hospitals to deliver data and lock it I don’t think it will be done until end of week. By this weekend however FDA may have enough info between CD-10 prob 80+ EIND’s plus maybe open label to grant an EUA earlier than many expect. Good things come to those who wait. I’m a patient long won’t be selling any shares for a long time. I see the full picture much like Black-Ops on other board.